Abstract

Curcumin is a potent anticancer molecule naturally derived from the spice turmeric and was combined with silk fibroin (SF) to improve its intracellular bioavailability. This study focused on the fabrication and characterization of SF nanoparticles loaded with curcumin (SF-curcumin) and evaluated their efficacy in vitro using a metastatic breast cancer cell line (GILM2). SF-curcumin nanoparticles were characterized for particle size, morphology, curcumin loading efficiency and release kinetics, efficacy against GILM2 cells, and protein expression profiles using protein microarray. Nanoparticles had an average diameter of 127.7±6.8nm and a bimodal distribution with most particles falling within the 70- to 110-nm range. SEM showed the nanoparticles had a spherical morphology and aggregated into grape-like structures, which was confirmed using dynamic light scattering. Curcumin release from the nanoparticles showed a typical profile with an initial burst release within the first 24 hours and continued release up to 7 days. The efficacy of SF-curcumin nanoparticles in vitro improved with increased concentration of curcumin and with time. Molecular effects of nanocurcumin on GILM2 cells targeted the high expression of AKT1. Our results indicate that SF nanoparticles may be an attractive nontoxic alternative for the systemic delivery of curcumin.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.